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Epac1 (also known as cAMP-GEF-I) and Epac2 (also known as cAMP-GEF-II) are 
cyclic AMP-activated guanine nucleotide exchange factors for Ras-like GTPases. 
Since their discovery about ten years ago, it is now accepted that Epac proteins are 
novel cAMP sensors that regulate several pivotal cellular processes, including 
calcium handling, cell proliferation, cell survival, cell differentiation, cell 
polarization, cell-cell adhesion events, gene transcription, secretion, ion transport, 
and neuronal signaling. Recent studies even indicated that Epac proteins might play 
a role in the regulation of inflammation and the development of cardiac hypertrophy. 
Meanwhile, a plethora of diverse effectors of Epac proteins have been assigned, such 
as Ras and Rho GTPases, phospholiase C-ε, phospholipase D, mitogen-activated 
protein kinases, protein kinase B/Akt, ion channels, secretory-granule associated 
proteins and regulators of the actin-microtubule network, the latter probably 
involved in the spatiotemporal dynamics of Epac-related signaling. This review 
highlights multi-faceted effectors and diverse biological functions driven by Epac 
proteins that might explain certain controversial signaling properties of cAMP.  
 
Introduction 
Members of the Ras superfamily of small GTPases are now considered to be pivotal 
regulators of fundamental cellular processes, such as cell proliferation, cell 
differentiation, cell maturation, cell migration, apoptosis, cytoskeletal 
rearrangements and contraction [1-3]. Based on sequence homology the Ras 
superfamily is divided now into five different branches, namely Ras (including Rap1 
and Rap2), Rho, Rab, Ran and Arf, and each branch is characterized by distinct 
signaling properties [1-3]. Small GTPases are activated upon stimulation of 
signaling pathways by extracellular stimuli and function as molecular switches, 
cycling between an inactive GDP-bound state and an active GTP-bound state. 
Guanine nucleotide exchange factors (GEFs) stimulate the GDP/GTP exchange 
activity of Ras-like GTPases and activate the switch, whereas GTPase-activating 
proteins (GAPs) accelerate the slow intrinsic GTPase activity of Ras-like GTPases 
and inactivate the switch [4-7]. Spatiotemporal dynamics of small GTPases, GEFs 
and GAPs likely provide a mechanism for the generation of distinct biological net 
outcomes of Ras signaling [8-10]. Several members of the GEF family sense the 
universal second messengers calcium and cyclic AMP (cAMP) [7, 11-15]. Since 
their discovery about ten years ago, much attention has been focused on Epac 
(exchange protein directly activated by cAMP) proteins, GEFs specific for Ras-like 
GTPases directly activated by cAMP [13, 14, 16]. Epac proteins seem to control 
several effector proteins and to regulate pivotal processes, including calcium 
handling, cell proliferation, cell survival, gene transcription, vesicle trafficking, 
secretion, exocytosis, ion transport, and neuronal signaling. Recent studies indicate 
that Epac proteins might play a role in inflammation and in the development of 
Epac effectors and biological functions 
 
 39 
cardiac hypertrophy [17-20]. Epac proteins seem to exert their biological function 
either alone and/or in concert with the major cAMP regulated effector protein kinase 
A (PKA), and A-kinase anchoring proteins (AKAPs), known to interact with PKA 
and cAMP phosphodiesterases (PDEs), seem to coordinate Epac-driven signaling 
[14, 21] (Fig. 1). It has been reported that Epac1 interacts with PDE4D3 within a 
cAMP-responsive multiprotein complex, which contains mAKAP, PKA, PDE4D3 
and Epac1 [22, 23]. In this review, we will discuss our current knowledge regarding 
effectors and biological functions of Epac proteins. The reader is also referred to 
several recent excellent reviews on this topic [13, 14, 16, 24, 25].  
 
Epac proteins 
Two isoforms of Epac, namely Epac1 (also known as cAMP-GEF-1) and Epac2 
(also known as cAMP-GEF-II), have been identified so far. Epac1 and Epac2 exhibit 
a distinct expression pattern in mature and developing tissues. In particular, Epac1 
mRNA is expressed ubiquitously, whereas Epac2 mRNA is predominantly 
expressed in the brain and endocrine tissues [26]. Epac2 is currently undetectable in 
all hematopoietic cell types [27], while Epac1 has been found to be expressed in 
human monocytes and macrophages [28], B and T cells [27], eosinophils, 
neutrophils, platelets and CD34-positive hematopoietic cells [17]. Epac proteins are 
localized to the plasma membrane, perinuclear regions, the nuclear membrane and 
mitochondria, and subcellular redistribution of Epac proteins appears to be tightly 
regulated during the cell cycle [29]. These findings indicate that cellular 
compartmentalization might play a prominent role to exert the diverse signaling 
properties of Epac proteins. Epac1 and Epac2 are multi-domain proteins consisting 
of an N-terminal regulatory region and a C-terminal catalytic region (Fig. 1). The N-
terminal regulatory domain bears a Dishevelled, Egl-10, Pleckstrin (DEP) domain 
implicated in membrane association and a high-affinity cAMP-binding domain 
(cAMP-B). Recently the cAMP-B domain of Epac1 has been found to interact with 
microtubules [30], while the entire N-terminal region might serve to direct Epac to 
mitochondria [29]. Epac2 additionally contains a second low-affinity cAMP-A 
domain of uncertain biological function. A Ras-exchange motif (REM) domain acts 
as an intramolecular bridge between the regulatory and the catalytic regions to 
stabilize the GEF domain. Epac proteins also bear a Ras-associating (RA) domain 
which is present in several Ras-interacting proteins. Until now, however, only Epac2 
has been shown to interact with GTP-bound Ras [31], while no interaction partners 
for the RA domain of Epac1 have been found yet. A CDC25 homology domain 
(CDC25HD) in the C-terminal catalytic domain exhibits GEF activity for Ras-like 
GTPases. X-ray crystallography studies of full-length Epac2, solved in the absence 
of cAMP, indicated the presense of autoinhibitory properties in the C-terminal 
region being relieved upon binding of cAMP [32]. Thus, cAMP binding to Epac 
might induce conformational changes releasing Epac proteins from their inhibitory 































Fig. 1. Epac: A novel cAMP sensor. A, The generation of the second messenger molecule 
cAMP upon stimulation of Gs-coupled and cAMP-elevating receptors is well established. It 
has generally been assumed that cAMP acts via protein kinase A (PKA) or cyclic nucleotide 
gated ion channels to elicit its cellular effects. The identification of the Epac proteins (also 
known as cAMP-GEFs) has profoundly changed this PKA/cAMP dogma. Recent studies 
indicate that such diverse signaling properties are coordinated by members of the A-kinase 
anchoring family. GPCRs, G protein-coupled receptors; AKAP, A-kinase anchoring protein; 
GEFs, guanine nucleotide exchange factors. B, Schematic representation of the domain 
organization of Epac proteins; DEP, Dishevelled, Egl-10, Pleckstrin domain; REM, Ras-
exchanger motif; RA, Ras-associating domain. C, Activation of Epac by the membrane 
permeable and Epac-specific cAMP analog 8-pCPT-2’-O-Me-cAMP leads to activation of 
effectors.  
 
Initial studies claimed that a higher concentration of cAMP is required to activate 
Epac rather than PKA. Recently, however, it has been reported that the binding 
affinity of cAMP for PKA and Epac is very similar (kd ~2,9 µM) [33]. Cellular 
compartmentalization of cAMP formation and effector protein availability may 
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decide whether Epac and/or PKA are activated in response to moderate cellular 
cAMP increases [33]. Indeed, using Epac-based fluorescence resonance energy 
transfer cAMP sensors, spatiotemporal dynamics of Epac signaling have been 
identified at the plasma membrane, cytoplasm, mitochondria and the nucleus in cell 
models, indicating that cellular cAMP concentrations rise to a level sufficient to 
activate Epac proteins [34-36]. Furthermore, spatiotemporal cAMP signaling has 
been reported to involve members of the AKAP family [21], and indeed a cAMP-
responsive multiprotein complex, including mAKAP-PKA-PDE43-Epac1 has been 
identified to be important for cAMP signaling in the heart [22, 23]. Meanwhile, 
membrane-permeable cAMP analogs have been characterized, such as 8-(4-
chlorophenylthio)-2’-O-methyl-cAMP (8-pCPT-2’-O-Me-cAMP) (Fig. 1), and these 
analogs are used as pharmacological tools to study cAMP effects driven by Epac 
independent of PKA [24, 37, 38]. To further validate Epac-dependent cAMP 
signaling, PKA inhibitors might be used, as Epac proteins are insensitive to PKA 
inhibitors [24]. Inhibition of Epac activation by the cAMP analog Rp-cAMPS has 
been reported in vitro, but this compound failed to inhibit Epac signaling in cell 
models (reviewed in [24]). Thus, specific pharmacological antagonists of Epac 
proteins are currently not available.  
 
Epac effectors and cellular functions 
Epac proteins were initially characterized as cAMP-activated GEFs for Rap1 and 
Rap2 [26, 39]. However, Epac proteins seem also to represent a molecular link 
between different members of the Ras superfamily [18, 31, 40, 41]. In addition, 
direct binding to and activation of R-Ras by Epac1 has been reported [42]. Epac 
proteins not only bind to Ras-like GTPases, but also interact with regulators of 
calcium-induced exocytosis and with the microtubule cytoskeleton network [43-45]. 
So far, Epac proteins are implicated in several diverse cellular responses, including 
secretion [41, 46], integrin-mediated cell adhesion [43, 47], formation of cell-cell 
junctions [48-51], cellular calcium handling [52-57], apoptosis [58], cardiac 
hypertrophy [18, 20], cell proliferation [59, 60], cell differentiation [28, 61] and gene 
expression [19, 20, 62]. In particular, Epac2 is implicated in calcium-induced insulin 
secretion from pancreatic β-cells [63, 64]. Together these findings confirm the 
importance of Epac proteins for cellular functioning. Epac proteins probably exert 
such distinct signaling properties upon signaling to a plethora of effector proteins 




























Fig.2. Epac: effectors and biological functions. (a) Schematic representation of the Epac 
signaling pathway. Second messenger-generating receptors involved in activation of Epac are 
indicated; small GTPases are shown in orange, other effectors are shown in blue, and distinct 
cellular responses are indicated in salmon. AC, adenylyl cyclase; PLD, phospholipase D; 
PLC, phospholipase C; mTOR, mammalian target of rapamycin; PKB, protein kinase B. 
Whereas Epac2 is recruited by activated H-Ras to the plasma membrane, the GEF activity of 
Epac1 is regulated by LC2 MAP1A, a microtubule-associated protein. Signaling of various 
GPCRs, receptor tyrosine kinases and integrin receptors may converge on the level of the 
diverse effectors of Epac proteins (not shown). 
 
Rap1 
Initially Rap1 has been reported to antagonize Ras signaling, but Rap1 is now 
implicated in the regulation of integrin-mediated cell adhesion and cadherin-
mediated formation of cell junctions [13, 65-68]. Rap1 is activated by different 
members of the GEF family including Epac1 and Epac2 [7, 26, 39, 69]. As reported 
for Epac proteins, Rap1 is localized to the plasma membrane and intracellular 
compartments, including the Golgi, lysosomes, endosomes and perinuclear regions 
[65, 70-72]. Initial studies in ovarian carcinoma OVCAR-3 cells indicated that 
Epac1-Rap1 signaling modulates integrin-mediated cell adhesion, as activation of 
Epac by 8-pCPT-2’-O-Me-cAMP enhanced cell adhesion to fibronectin [47]. 
Meanwhile, it has been shown that Epac-Rap signaling controls integrin-mediated 
cell adhesion in several cell types, including monocytic U937 cells and freshly 
isolated human monocytes [17]. Rap1 might regulate integrin-mediated cell 
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adhesion via cellular redistribution of integrins and/or via conformational alterations 
of integrins, but the exact molecular mechanisms are currently still under 
investigation. Epac1-Rap1 signaling has also been implicated in the regulation of 
cell-cell adhesion and endothelial barrier functioning, cellular processes known to 
involve members of the cadherin family [73]. In Madin-Darby canine kidney cells, 
Epac1-Rap1 signaling has been reported to regulate E-cadherin-mediated cell-cell 
adhesion [74]. Recent studies in endothelial cells indicated that Epac1-Rap1 
signaling enhanced endothelial barrier functioning, a process probably involving 
redistribution of E-cadherin and recruitment of other cell junction molecules to cell-
cell contacts [49, 50]. Of interest, it has been shown that the level of Epac1 increased 
3-fold during differentiation of monocytes into mature macrophages and that the 
Epac1-Rap1 pathway was operational in mature macrophages, but not in monocytes 
[28]. Recently, it has been reported that Gs-coupled and cAMP-elevating receptors 
regulate inflammation through activation of Epac1-Rap1 signaling in monocytes 
[17]. In addition, Epac-Rap1 has been reported to modulate inflammatory processes 
in vascular endothelial cells upon induction of the “suppressor of cytokine signalling 
3” [19]. Thus, evidence has been provided that Epac1-Rap1 signaling might not only 




Activation of Rap2 by Epac1 and Epac2 has been reported. In addition, it has been 
shown that Rap2 is localized to the plasma membrane and intracellular 
compartments [7, 26, 39, 69]. Until now, however, our current knowledge about 
Rap2 effectors and Rap2-driven cellular responses is rather limited. Importantly, we 
reported that Gs-coupled and cAMP-elevating receptors stimulate a novel member of 
the phosphatidylinositol 4,5-bisphosphate (PIP2)-specific phospholipase C family, 
namely PLC-ε, through activation of Rap2 via Epac. Activation of PLC-ε by Epac 
and Rap2 then results in the generation of inositol-1,4,5-trisphosphate, leading to 
increases in cellular calcium [52, 55]. Based on these findings we have shown that 
Epac-Rap2-PLC-ε- induced activation of H-Ras and extracellular signal-regulated 
kinases 1 and 2 (ERK1/2) by a calcium-regulated Ras-GEF [75]. Gi-coupled and 
cAMP-reducing receptors inhibited the Epac-Rap2-PLC-ε- driven cellular responses 
[76]. Interestingly, PLC-ε seems to represent a molecular link between the universal 
second messengers calcium and cAMP and members of the Ras superfamily of small 
GTPases, including Ras, Rap and Rho (reviewed in [77]) (Fig. 3). The novel PLC 
family member PLC-ε is characterized by the presence of a N-terminal CDC25 
domain possessing GEF activity for some Ras-like GTPases and two C-terminal RA 
domains, providing upstream and downstream interactions and potential feedback 
mechanisms with Ras-like GTPases [78-80]. PLC-ε is abundantly expressed in 
different tissues, including the heart [78, 79, 81], and as reported for Epac proteins, 




Intriguingly, recent studies in mice deficient for the Epac effector PLC-ε indicated 
that stimulation of calcium-induced calcium release by the typical Gs-coupled β-
adrenoceptor required Epac-Rap-PLC-ε in cardiac myocytes [53, 56]. These findings 
are the first indication that Epac driven PLC-ε might be important for cardiac 
functioning, but the physiological impact of Epac-driven calcium dynamics in the 
heart still requires further investigation. Whether Epac1 and Epac2 induce the 
cAMP-dependent PLC-ε stimulation not only upon activation of Rap2, but rather 
also upon activation of Epac-regulated Rap1 and R-Ras remains to be studied. 
Beside PLC-ε, Rap2 might activate the c-Jun N-terminal kinase (JNK) via mitogen-
activated protein kinase kinase kinase kinase 4, and might regulate the actin 
cytoskeleton via Traf2- and Nck-interacting kinase [82, 83]. In addition, it has been 
shown that Rap2 is required for Wnt/β-catenin signalling pathway in Xenopus early 
development [84]. As developmental changes of Epac expression has been reported 
as well [20], these findings might indicate that Epac-Rap2 signaling modulate 
cellular growth via diverse effector proteins. 
 
R-Ras 
As member of the Ras superfamily of small GTPases, R-Ras interacts with several 
different GEFs and GAPs [7, 15]. Importantly, we have shown recently that Epac1 
directly binds to and activate R-Ras [42]. R-Ras has been reported to play a role in 
the regulation of various aspects of integrin-mediated cell adhesion, and thus R-Ras 
might modulate integrin signaling in concert with Rap1 [66, 85, 86]. Recently, R-
Ras has been implicated in the regulation of cellular calcium handling as well. It has 
been reported that R-Ras triggers alterations in cellular calcium handling probably 
upon decreasing the calcium content of the endoplasmatic reticulum [87]. In addition, 
it has been shown that activation of PLC-ε by R-Ras altered the cellular calcium 
content [88]. As Epac is capable to both activate R-Ras and PLC-ε, such Epac-
driven signaling properties might converge on the level of PLC-ε to modulate 
cellular calcium handling (Fig. 3). We reported recently that activation of R-Ras by 
Epac induces stimulation of phospholipase D (PLD) [42]. PLD enzymes hydrolyze 
phosphatidylcholine of cell membranes to phosphatidic acid (PA) in response to 
stimuli, and are considered to be involved in a large variety of early and late cellular 
responses, including calcium mobilization, secretion, exocytosis, cytoskeleton 
rearrangement, cell proliferation and apoptosis [89]. Importantly, PLD-generated PA 
is implicated in the regulation of  the mammalian target of rapamycin (mTOR) [90], 
a phosphatidylinositol 3-kinase (PI 3-kinase)-regulated effector protein known to be 
involved in the regulation of gene transcription and cell-cycle progression [91-93] 
(Fig. 2). Epac has been reported to induce R-Ras-dependent PLD stimulation [42], 
and it has been shown that Epac modulates cellular PI 3-kinase responses [60, 94]. 
These findings suggest that Epac signaling might control gene expression and cell 
proliferation through activation of PLD, a process probably involving R-Ras and PI 
3-kinase. 

























Fig.3. Regulation of the Epac effector PLC-ε by second messengers and members of the 
Ras superfamily. Activation of Epac proteins upon stimulation of Gs-coupled and cAMP-
elevating receptors (e.g. β2-adrenergic receptors, E1 prostanoid receptor and M3 muscarinic 
receptors) induce PLC-ε-dependent elevations in cellular calcium upon GTP-loading of the 
Ras-like GTPase Rap2B. As Epac 1 directly binds to and activate R-Ras, Rap2B might act in 
concert with R-Ras to modulate PLC-ε signaling. Activation of PLC-ε by receptor tyrosine 
kinase (RTKs) (e.g. platelet-derived growth factor receptor and epidermal-derived growth 
factor (EGF) receptor) has been shown to involve Rap (Rap1 and Rap2B) and Ras. In 
particular, activation of Rap2 by EGF seems to involve a calcium-regulated GEF. Activation 
of PLC-ε upon stimulation of G12/13-coupled receptors (e.g. receptor for lysophosphatidic 
acid) or the surface protein CD44 has been shown to involve Rho, the latter being activated 
by p115 Rho-GEF or LARG, respectively. Wherase activation of PLC-ε by Rho seems to 
involve a unique Y insert in the cataytic core, activation of PLC-ε by Rap and Ras seems to 
involve the two C-terminal RA domains. In addition, PLC-ε bears a N-terminal CDC25 
domain thereby exhibiting GEF activity to Rap1 and Ras. These mechanisms probably 
provide upstream and downstream interactions with small GTPases. PLC-ε-driven calcium 
elevations might contribute to the activation of calcium-regulated GEFs. However, the 
impact of such diverse feed-forward and/or feed-back regulatory mechanisms between PLC-ε 
and members of the Ras superfamily and second messengers remains to be studied. PH, 






Mitogen-activated protein kinases 
Several studies indicate that Rap1 modulates mitogen-activated protein kinase 
(MAPK) responses, in particular of ERK1/2 [95]. Rap1 induces ERK1/2 stimulation 
or inhibition depending on specific cell types, and cellular compartmentalization 
might define signaling specificity. Meanwhile, Epac-Rap signaling triggered upon 
stimulation of various receptors has been reported to activate ERK1/2 in several cell 
types, including FRTL5 cells [96], native rat kidney cells [97], cultured rat 
hippocampal neurons and PC12 cells [98], HEK-293 cells and N1E-115 
neuroblastoma cells [75], osteoblast [96, 99], and human umbilical vein endothelial 
cells [100]. In addition, it has been reported that even productive coupling between 
Epac-Rap did not result in activation of ERK1/2 [38, 101]. It has been proposed that 
Epac-triggered activation of ERK1/2 by Rap1 is dependent on the mode of Rap 
activation, i.e. a plasma membrane pool of Rap1 colocalized with Epac must be 
activated in order to trigger ERK1/2 responses [101]. In addition, it has been shown 
that Epac activates JNK, a member of the MAPK family [102, 103]. Strikingly, 
activation of JNK by Epac was independent of its GEF activity [102]. Activation of 
MAPKs by Epac has not only been implicated in the regulation of cell proliferation 
and cell-cycle regulation, but rather also in the modulation of ion channels [97] and 
regulation of gene expression [62]. 
 
Rho GTPases 
Activation of Rho GTPases in response to diverse extracellular stimuli is known to 
play a pivotal role in the regulation of actin dynamic-dependent processes, including 
cell polarization, cell migration and contractility [104, 105]. Interaction of Epac 
proteins with the microtubule cytoskeleton network has been described to control 
their GEF activity [43], indicating that actin dynamics might play a central role in 
the regulation of Epac signaling properties. Regulation of the Epac effector PLC-ε 
by members of the Ras superfamily, namely R-Ras and most importantly Rho 
GTPases, has been shown to modulate actin-driven processes such as the formation 
of membrane protrusions [88] and cell migration [106]. The Epac effector Rap1 has 
been reported to increase the GAP activity of ARAP3 towards RhoA and to inhibit 
RhoA-dependent formation of membrane protrusions [40]. Such process may present 
a molecular link between Rap1 and RhoA. Recently, it has been shown that Epac-
Rap1 enhances endothelial barrier functioning in human pulmonary artery 
endothelial cells, a process requiring activation of Rac by a Tiam1/Vav2-dependent 
pathway [48]. Recruitment of Rac via Tiam1/Vav2 signaling to defined membrane 
areas at the cell periphery seems to trigger endothelial barrier functioning by Epac-
Rap1. Rac might be also important for the regulation of integrin-mediated cell-cell 
adhesion events by Epac-Rap1, as Rac recruitment to the plasma membrane is under 
control of integrins [107, 108]. Strikingly, evidence has been provided that secretion 
of the amyloid precursor protein by Epac-Rap1 requires Rac in various cell types, 
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including primary cultures of mouse cortical neurons [41]. Meanwhile, it has been 
reported that the α-secretase-induced cleavage or “shedding” of the amyloid 
precursor protein ectodomain by members of the matrix metalloproteinase family, 
namely ADAMs (a disintegrin and metalloproteases), involves Epac proteins [46]. 
Matrix metalloproteinases are now considered to be pivotal regulators of actin-
driven processes, including cell proliferation and cell migration [109, 110]. As Epac 
driven signaling to Ras and Rho GTPases seems to modulate actin dynamics,  it is 
reasonable to assume that regulation of matrix metalloproteinases by Epac proteins 
might contribute to such cellular events. 
 
Ion channels, ion transporters and Ca2+ signaling 
It is generally accepted that cAMP profoundly modulates ion channel functioning 
[11]. Several recent studies point to a major role of Epac proteins in the cAMP-
dependent regulation of ion channels [63]. It has been reported that Epac2 inhibits 
the ATP-sensitive potassium channel (KATP-channel) in human pancreatic β-cells 
[111]. Such process involved direct interaction of Epac2 with the sulphonylurea 
receptor-1 (SUR-1) subunit of the KATP channel and has been now implicated in the 
regulation of insulin release from pancreatic β-cells [45, 63, 64, 111]. Of interest, it 
has been shown recently that the PLC-substrate PIP2 stimulates the activity of KATP-
channels upon reducing their sensitivity to ATP [112]. Strikingly, PLC-ε has been 
reported to cleave PIP2 upon stimulation through cAMP-dependent Epac proteins 
[52, 53, 55, 56, 76]. Thus, Epac-driven PLC-ε responses might contribute to the 
inhibitory effects of cAMP on KATP channel activity. Activation of Ca2+ and Cl- 
channels by glucagon in rat hepatocytes seems also to involve Epac proteins, 
probably Epac2 known to be expressed in these cells [113]. Whether Epac-
dependent regulation of Ca2+ and Cl- channels is mediated by PLC signals remains to 
be determined. As reported for the ATP-dependent H+-K+ transporter in rat kidney 
cortical collecting duct cells [97], and for the Na+-H+ exchanger isoform 3 in kidney 
cells [114], Epac proteins regulate the activity of ion transporters, but the underlying 
molecular mechanisms are unknown yet. Recent findings indicate that cAMP-
regulated Epac proteins positively regulate cellular calcium increases. Stimulation of 
calcium-induced calcium release (CICR) by the Epac activator 8-pCPT-2’-O-Me-
cAMP induced insulin secretion from human pancreatic β-cells and insulin-secreting 
cell lines, a process being sensitive to dominant negative Epac2 [64]. Epac proteins 
might regulate CICR through KATP channels, ryanodine receptors and Rap1-sensitive 
sarco-endoplasmic reticulum Ca2+-ATPases [63, 64, 115]. A recent report indicates 
that Epac-Rap1 activates p38 MAPK in cerebellar neurons, a process enhancing 
cellular calcium through modulation of calcium-dependent K+ channels [116]. Such 
mechanism might indicate a role for Epac proteins in the regulation of neuronal 
excitability. Finally, it is now accepted that the novel Epac-Rap-PLC-ε pathway 
regulates cellular calcium handling [52, 53, 55, 76]. Indeed, cardiac myocytes from 




and cAMP-elevating receptors [53, 56]. Epac proteins probably acting in concert 
with PKA might not only regulate normal cardiomyocytes physiology [53], but 
might contribute also to developmental and pathophysiological alterations in the 
heart, as reported recently [20]. 
 
Exocytosis  
Stimulus-secretion coupling is an important event in several secretory cells to 
control the exocytosis machinery [25, 117]. Epac proteins regulate exocytotic 
processes in non-neuronal and neuronal cell types, including insulin secretion from 
pancreatic β-cells [118] and the release of glutamate release at crayfish 
neuromuscular junctions [119]. Interaction of Epac proteins with secretory-granule 
associated proteins, including Rim (Rab3-interacting molecule) and Rim2 [45, 120], 
might play a role in the regulation of exocytosis. In pancreatic β-cells interaction of 
Epac2 with a secretory-granule membrane-associated pool of the SUR-1 subunit of 
KATP channels induces opening of ClC-3 Cl- cloride channels causing Cl- influx into 
secretory granules creating an electromotive force facilitating ATP-dependent H+ 
uptake by a v-type H+-ATPase [121, 122]. Such acidification stimulates the 
“priming” of secretory granules, thereby rendering them release-competent. It has 
even been hypothesized that Epac2 might act in a more direct manner to up-regulate 
the activity of the v-type H+-ATPase channels [63]. Based on our current knowledge, 
Epac proteins seem to regulate exocytosis either through interaction with secretory-
granule associated proteins or regulation of ion channels.  
 
Microtubules 
Microtubules are believed to act in concert with the actin cytoskeleton to regulate 
diverse cellular responses, including cell polarization, cell division and cell 
migration, and contribution of cAMP-dependent processes is organized through 
members of the AKAP family [123-125]. Recently, interaction of Epac proteins with 
microtubules and/or microtubule-associated proteins has been identified [44, 126], 
suggesting that Epac proteins participate in the cAMP-dependent regulation of the 
microtubule network. In particular, Epac1 has been shown to bind to the light chain 
2 (LC2) of the microtubule-associated protein MAP1A, the latter known to interact 
with the actin-microtubule network by catalyzing polymerization and stabilization of 
microtubules [43, 127]. It has also been reported that LC2 enhances activation of 
Rap1 by Epac1 [43], suggesting that the GEF activity of Epac proteins is under 
control of the microtubule network. As MAP1 proteins are multi-subunit protein 
complexes known to modulate cellular responses, LC2 may serve as an anchor to 
promote the interaction of Epac proteins with the microtubule network [128]. 
Strikingly, it has been reported that the Rho-specific nucleotide exchange factor 
GEF-H1 connect microtubule network alterations to Rho-dependent signaling [129]. 
As binding of LC2 to Epac proteins probably enhances the affinity of the cAMP-
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binding domains for cAMP [126], it might seem reasonable to suggest that the 
stability of the microtubule network define the ability of Epac proteins to activate 
Rap. Since Epac proteins have been reported to associate with the microtubules of 
the mitotic spindle [29], LC2 might also maintain Epac activity during cell division.  
 
Others 
Promiscuity is presumably the most striking feature of Epac driven signaling. As 
novel cAMP sensors Epac proteins modulate multi-faceted effectors and diverse 
biological functions. In order to explain signaling properties of cAMP still being 
unclear and controversial, Epac related research has attracted much attention over 
the last ten years. Of particular interest in this context, a recent study indicating that 
Epac proteins mediate the cAMP-dependent activation of the small GTPase Rit, the 
latter known to be important for neurotrophin signaling [61, 130]. It has been shown 
that Epac1 is required for the activation of Rit by the Gs-coupled and cAMP-
elevating pituitary adenylate cyclase-activating polypeptide receptor, a process 
independent of Rap and independent of direct activation of Rit by Epac1 or Epac2. 
As pituitary adenylate cyclase-activating polypeptide receptors are known to 
regulate neuronal processes, including neuronal differentiation, neuronal 
proliferation and neuronal survival [131], these findings suggest that Epac proteins 
might regulate learning and memory processes. An additional new research line 
represents the relation between Epac and protein kinase B (PKB)/Akt, the latter 
known to control many vital processes, including cell proliferation and cell survival 
upon modulation of gene transcription [132]. The role of cAMP in the regulation of 
cell proliferation is still a matter of debate: cAMP stimulates proliferation in certain 
cell types, while it inhibits proliferation in other cell types [11, 95]. Recent studies 
implicate that Epac proteins might be involved in these opposing effects of cAMP on 
cell proliferation. Activation of PI 3-kinase-dependent Akt signaling by Epac 
proteins has been shown in WRT cells [59]. Epac-dependent activation of Akt 
increased gene expression and proliferation of macrophages, a process depending on 
Rap1. In addition, it has been hypothesized that activation of Akt by Epac requires 
its recruitment to the plasma membrane [60]. However, depending on the stimuli the 
cells are exposed to, cAMP-induced Epac activation can either stimulate or inhibit 
Akt phosphorylation probably through interaction with distinct effectors [94, 133, 
134]. For example, it has been reported that Epac proteins induced a decrease in Akt 
phosphorylation in adipocytes presumably upon modulation of cAMP-reducing 
phosphodiesterases 3B and E4 [135]. These results implicate that cell type 
specificity determines the crosstalk between Epac and PKB/Akt, a process probably 






In the last decade, Epac proteins have been recognized to play a central role in the 
regulation of cAMP-driven cellular processes upon signaling to diverse effectors. 
Several properties of Epac proteins still need to be elucidated. Additional studies on 
the structures of Epac1 and Epac2 in the absence and presence of cAMP will 
certainly extent our current knowledge of their mode of activation and regulation. 
Studies on the molecular nature of the interaction of Epac proteins with their diverse 
effectors are also warranted. Without doubt, the development of Epac specific 
pharmacological antagonists and mice deficient in Epac proteins would be very 
helpful. Of particular interest is the relationship between Epac and PLC-ε-calcium 
signaling, which represents a molecular link between the two universal second 
messengers calcium and cAMP. Epac proteins are known to activate Ras-like 
GTPases, which in turn bind and activate PLC-ε, thereby modulating cellular 
calcium handling. Strikingly, PLC-ε bears beside the typical PLC-defining 
catalytical domains a CDC25 domain, which exhibits GEF activity to the identical 
subset of small GTPases known to activate PLC-ε (reviewed in [77]) (Fig. 3). Indeed, 
it has been reported that the PLC-ε-specific CDC25 homology domain activate Rap1 
leading to sustained Rap1 signaling [136], indicating that PLC-ε acts both 
downstream and upstream of Ras-like GTPases. In this context, also activation of 
Rap1 has been proposed to occur downstream of PLC-ε-dependent activation of R-
Ras [85, 88]. It should be noted, however, that PLC-ε-driven PIP2 hydrolysis might 
alter cellular responses by mechanisms independent of calcium, as alterations in the 
cellular PIP2 content are known to regulate several cellular processes as well [137]. 
To decipher the role of the diverse effectors mediating Epac responses and to 
understand the impact of the spatiotemporal dynamics of Epac signaling are the 
important challenges for future research in this exciting field of signal transduction. 
 
Concluding remarks 
Our current knowledge about effectors and biological functions of Epac proteins is 
still incomplete and controversial. Studies on the developmental expression pattern 
of Epac and changes in expression under pathophysiological circumstances are still 
rather limited. However, initial studies indicate that Epac proteins might be 
important for the regulation of inflammatory processes and the development of 
cardiac hypertrophy. The interaction of Epac proteins with matrix metalloproteinases 
implicates that Epac signaling might play a key role in several aspects of tissue 
remodeling. The involvement of Epac in insulin secretion and amyloid precursor 
protein secretion might indicate that Epac signals are relevant for future treatment of 
several devastating disorders, including Type II diabetes and Alzheimer’s disease. 
 




Within the last ten years our knowledge about the impact of Epac-driven signaling 
routes has increased remarkably, and novel Epac related signaling properties are 
published every week. Unfortunately, as for space limitations we were not able to 
include all recent work on Epac. We thank Dr. Oude Weernink for critical reading of 
the manuscript. Sara S. Roscioni is recipient of an Ubbo Emmius Fellowship from 
the School of Behavioral and Cognitive Neurosciences (BCN), University of 
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